Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

Director Kim Helen Susan converted options into 4,994,212 shares and bought $15,030,000 worth of shares (835,000 units at $18.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKTS· Aktis Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.